MedicineBiology

Akt signalling in health and disease.

I. Hers, E. Vincent, J. Tavaré

2011.10.1CELLULAR SIGNALLING

DOI: 10.1016/j.cellsig.2011.05.004

tlooto Summary

The types of Akt inhibitors that have been developed and are in clinical trials for human cancer, as well as speculate on potential on-target toxicities, such as disturbances of heart and vascular function, metabolism, memory and mood, should be monitored very carefully during clinical trial.

Abstract

Abstract is not available.

Citation format

HERS, I.; VINCENT, E.; TAVARÉ, J. Akt signalling in health and disease. CELLULAR SIGNALLING, 2011, 23 10: 1515–27.